Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
$146M |
| 2 |
Pfizer
PFE
|
$114M |
| 3 |
JPMorgan Chase
JPM
|
$103M |
| 4 |
Exxon Mobil
XOM
|
$89.1M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$82.9M |
Top Sells
| 1 |
FON
SPRINT CORP FON COM
FON
|
$201M |
| 2 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
$182M |
| 3 |
Zoetis
ZTS
|
$106M |
| 4 |
Goldman Sachs
GS
|
$77.8M |
| 5 |
Centrus Energy
LEU
|
$77.1M |
Sector Composition
| 1 | Financials | 19.02% |
| 2 | Industrials | 12.9% |
| 3 | Energy | 11.13% |
| 4 | Technology | 9.45% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
POSCO
PKX
$15.6B
| $242M | 0.21% | 3,291,390 +14,015 | +0.4% | +$1.03M |
|
52
Alphabet (Google) Class C
GOOG
$2.58T
| $240M | 0.21% | 274,574 +11,563 | +4% | +$10.1M |
|
53
NOV
NOV
$4.94B
| $239M | 0.21% | 3,065,673 +38,381 | +1% | +$3M |
|
54
Intel
INTC
$107B
| $239M | 0.21% | 10,419,077 +3,019,041 | +41% | +$69.2M |
|
55
Merck
MRK
$210B
| $234M | 0.2% | 4,919,182 -27,542 | -0.6% | -$1.31M |
|
|
56
Goldman Sachs
GS
$226B
| $233M | 0.2% | 1,470,904 -491,630 | -25% | -$77.8M |
|
57
Cisco
CSCO
$274B
| $229M | 0.2% | 9,794,460 -325,575 | -3% | -$7.62M |
|
|
MRO
58
DELISTED
Marathon Oil Corporation
MRO
| $225M | 0.19% | 6,456,198 +36,790 | +0.6% | +$1.28M |
|
59
APA Corp
APA
$8.31B
| $224M | 0.19% | 2,628,245 +94,363 | +4% | +$8.03M |
|
|
BRS
60
DELISTED
Bristow Group, Inc.
BRS
| $223M | 0.19% | 3,060,580 +5,131 | +0.2% | +$373K |
|
|
ESRX
61
DELISTED
Express Scripts Holding Company
ESRX
| $222M | 0.19% | 3,587,172 +1,341,480 | +60% | +$82.9M |
|
62
Northrop Grumman
NOC
$84.5B
| $221M | 0.19% | 2,319,003 -31,416 | -1% | -$2.99M |
|
63
Bank of New York Mellon
BK
$74.5B
| $221M | 0.19% | 7,314,240 +137,386 | +2% | +$4.15M |
|
|
HES
64
DELISTED
Hess
HES
| $220M | 0.19% | 2,841,393 +12,125 | +0.4% | +$938K |
|
65
UnitedHealth
UNH
$281B
| $217M | 0.19% | 3,035,559 +3,844 | +0.1% | +$275K |
|
66
CME Group
CME
$96B
| $217M | 0.19% | 2,934,111 +12,844 | +0.4% | +$949K |
|
67
General Motors
GM
$55.8B
| $217M | 0.19% | 6,025,236 +891,734 | +17% | +$32.1M |
|
68
Archer Daniels Midland
ADM
$30.1B
| $216M | 0.19% | 5,868,701 +28,966 | +0.5% | +$1.07M |
|
69
Helix Energy Solutions
HLX
$969M
| $209M | 0.18% | 8,226,451 -72,036 | -0.9% | -$1.83M |
|
70
Marathon Petroleum
MPC
$54.6B
| $209M | 0.18% | 3,244,249 -5,879 | -0.2% | -$378K |
|
|
ESL
71
DELISTED
Esterline Technologies
ESL
| $207M | 0.18% | 2,594,244 +41,828 | +2% | +$3.34M |
|
72
Prologis
PLD
$106B
| $203M | 0.18% | 5,406,654 +277,220 | +5% | +$10.4M |
|
73
Healthpeak Properties
DOC
$12.5B
| $202M | 0.17% | 4,929,755 +132,077 | +3% | +$5.41M |
|
|
SNP
74
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $201M | 0.17% | 2,563,246 +574,050 | +29% | +$44.9M |
|
75
Gerdau
GGB
$6.15B
| $200M | 0.17% | 26,837,051 +1,675,561 | +7% | +$12.5M |
|